The 340B program provides relief from high prescription drug prices for providers serving low-income communities though discounts to eligible facilities directly from drug manufacturers. The Stretching Entity Resources for Vulnerable Communities Act would reverse a recent cut to Medicare payments to 340B hospitals and require drugmakers to publicly disclose drug-pricing information.
“The savings gleaned from the 340B program allow hospitals to make critical, cost-effective investments to improve the health and well-being of their communities,” said Carmela Coyle, president and CEO of the hospital association. “This legislation will improve the integrity and transparency of the program, while enabling hospitals to continue to be exemplary stewards of these vital resources.”
More articles on leadership and management:
Ex-board member: Nashville General hid $150K contract with former councilman
Physician neighbor allegedly attacked Sen. Rand Paul last year over messy lawn
Viewpoint: Nurses deserve more recognition for innovation
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.